ABSTRACT: Avascular (Avas) meniscus regeneration remains a challenge, which is partly a consequence of our limited knowledge of the cells that maintain this tissue region. In this study, we utilized microarrays to characterize gene expression profiles of intact human Avas meniscus tissue and of cells following culture expansion. Using these data, we examined various 3D culture conditions to redifferentiate Avas cells toward the tissue phenotype. RNA was isolated from either the tissue directly or following cell isolation and 2 weeks in monolayer culture. RNA was hybridized on human genome arrays. Differentially expressed (DE) genes were identified by ranking analysis. DAVID pathway analysis was performed and visualized using STRING analysis. Quantitative PCR (qPCR) on additional donor menisci (tissues and cells) were used to validate array data. Avas cells cultured in 3D were subjected to qPCR to compare with the array-generated data. A total of 387 genes were DE based on differentiation state (>3-fold change; p < 0.01). In Avascultured cells, the upregulated pathways included focal adhesion, ECM-receptor interaction, regulation of actin cytoskeleton, and PDGF Signaling. In 3D-cultured Avas cells, TGFb1 or combinations of TGFb1 and BMP6 were most effective to promote an Avas tissue phenotype. THBS2 and THBS4 expression levels were identified as a means to denote meniscus cell phenotype status. We identified the key gene expression profiles, new markers and pathways involved in characterizing the Avas meniscus phenotype in the native state and during in vitro dedifferentiation and redifferentiation. These data served to screen 3D conditions to generate meniscus-like neotissues. ß
The meniscus distributes load, stabilizes knee joints, and protects articular cartilage during normal locomotion. Secondary osteoarthritis (OA) is commonly a consequence of damaged or degenerated meniscus. 1, 2 The estimated incidence of meniscal injury in the United States is between 600,000 and 850,000 with 90% of these requiring surgical intervention. [3] [4] [5] While tears in the vascular zone can sometimes be surgically repaired, 5, 6 the outcomes for tears in the avascular zone are dismal with around 30% of these repairs leading to re-rupture. 5 Meniscus is a complex tissue that possesses anisotropic mechanical attributes to accommodate compressive and tensile loading 7 and is organized into various regions with divergent features. The vascular zone contains fibroblast-like cells surrounded by an extracellular matrix (ECM) that is low in glycosaminoglycan (GAG) content and consists mainly of collagen type I. The inner wedge of tissue is avascular and contains cells that have a chondrocyte-like morphology, which have been termed as fibro-chondrocytes. 8 The ECM composition around the fibro-chondrocytes consists of collagen types I and II, aggrecan, and chondroitin sulfate. 5 At the very surface of the meniscus are superficial zone cells, which may also include a progenitor cell population. 9, 10 However, the cellular characteristics used to define meniscus cell subpopulations have been limited. To repair or regenerate meniscus using a cell-based method, it is critical to focus on understanding the biology of meniscus. The major variables for typical cell-based approaches are finding a suitable cell source and culture expansion to the requisite cell numbers. While cells of meniscal origin seem most appropriate, 11, 12 they are difficult to obtain clinically. Alternative cell sources have been assessed for their capacity to generate meniscus-like tissues. These include chondrocytes, 13, 14 bone marrow-derived mesenchymal stem cells (BM-MSC), 15, 16 synovium-derived stem cells, 17, 18 infrapatellar fat pad progenitors, 17 and adipose-derived stem cells (ADSC) 19, 20 have been tested. However, the target phenotype of a meniscogenic cell is poorly defined.
Microarray studies have documented changes in the mouse meniscus during embryologic development 21 and changes in human meniscal cells in response to aging, injury, and OA. [22] [23] [24] Less is known with regard to changes in phenotype during culture expansion, which is critical for tissue engineering. In the case of articular cartilage, culture-induced dedifferentiation of the isolated chondrocyte has been extensively studied with the characteristic shift in ECM production of collagen type II to collagen type I [25] [26] [27] and from aggrecan to versican production, 28, 29 as well as changes in several cell surface molecules such as a shift in the CD14/CD90 ratio. 28 Three dimensional (3D) culture in hydrogels or as high-cell density pellet cultures supplemented with growth factors (principally transforming growth factor beta, TGFb) can successfully induce "redifferentiation" of the articular chondrocyte phenotype. 26, 30 Meniscal cells also appear to undergo monolayer culture-induced dedifferentiation with a loss of Collagen type II, cartilage oligomeric matrix protein (COMP) and with increased Collagen type I. 31 Various high-density cell culture systems, in concert with growth factors such as TGFb3, 32, 33 insulin-like growth factor 1 (IGF-1), 34 and fibroblast growth factor 2 (FGF2) 34, 35 mechanical stimulation, [36] [37] [38] and hypoxic conditions 39 can induce some reversion to a meniscus phenotype. Nevertheless, currently there is a lack of comprehensive phenotype markers to indicate what constitutes a normal meniscus tissue and even less is known regarding the spectrum of states between the differentiated and dedifferentiated meniscal cell. In addition, there are no optimal guidelines for conditions to induce a normal meniscus phenotype in an alternative cell source.
The goal of our study was to identify gene expression profiles and pathways in native human avascular meniscus cells that changed significantly during culture-induced dedifferentiation using microarrays. We then assessed the potential for 3D culture conditions to induce the formation of meniscus-like tissues from human avascular meniscus cells.
METHODS
The study was designed in three phases: i) initial microarray screen; ii) validation of microarray findings by qPCR; and iii) cellular 3D culture.
Tissue and Cell Sources
For the initial array studies, normal human medial and lateral menisci were harvested from two donors (22-and 23-year-old males) from tissue banks (approved by Scripps Institutional Review Board) within 48 h of death. For validation experiments via qPCR, RNA was isolated from either tissue or cultured avascular cells from normal avascular menisci from three additional donors (one 25-and two 35-year-old males).
In experiments designed to screen various growth factors in 3D conditions, four donors were used to examine the effects of TGFb1 (one female and three males, age range: 28 AE 4 years) and an additional four donors were utilized in 3D high-density pellets with combinations of TGFb1 and Bone Morphogenetic Protein 6 (BMP6) (one female and three males, all 23-years-old).
Tissue Processing
Tissue from the avascular (inner 2/3) region of the medial and lateral menisci from a given donor was dissected and minced. The tissue from each donor and condition was maintained and processed separately. This tissue was divided for direct total RNA isolation or for cell isolation and culture. For RNA isolation from tissue, the minced tissue was immersed in RNAlater TM (Life Technologies, Grand Island, NY) and then was pulverized in liquid nitrogen (Freezer/Mill 6770, SPEX SamplePrep, Metuchen, NJ) before being processed for total RNA isolation using the RNeasy kit (Qiagen, Valencia, CA). For cell isolation, the minced tissue was subjected to collagenase (2 mg/ml, C5138, Sigma-Aldrich, St. Louis, MO) for 6 h. The isolated cells were cultured in medium composed of DMEM (Mediatech, Inc, Manassas, VA) supplemented with 10% calf serum (Omega Scientific Inc. Tarzana, CA) and 1% penicillin/streptomycin/gentamycin (Gibco, Carlsbad, CA) for 2 weeks in monolayer culture with medium changes every 3-4 days. Cultured cells were removed from the cultured surface using Accutase (Innovative Cell Technologies, Inc., San Diego, CA) and were washed in PBS before using the RNeasy kit (Qiagen) for RNA extraction.
Micro Array
At least 100 ng of total RNA from each donor and each treatment condition was separately extracted and prepared for pre-hybridization, without pooling (Total Prep Kit, Illumina, San Diego, CA) and hybridized on the human genome array from Illumina (HuHT-12_v4) following the manufacturer's instructions.
Array Data Analysis
The Bioconductor:Lumi Package (Bioconductor-illuminaHumanv4, http://www.bioconductor.org) was used for processing the data (Robust Multi-array Average (RMA] normalization) and to rank and identify differentially expressed (DE) genes in monolayer culture in comparison to the native tissue. The data for each treatment condition (Supplementary Material, Tables S1 and S2) include the following data output values: estimate of the log2-fold-change corresponding to the effect or contrast (logFC), magnitude of fold change (MagFC), average log2-expression for the probe over all arrays and channels (AveExpr), moderated t-statistic (t), the raw p values (p value) and the adjusted p values (adj.P.Val). Pathway analyses were conducted using DAVID (http:// david.abcc.ncifcrf.gov). To visualize and to identify major interaction between DE genes in either the native or the dedifferentiated states, the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) analysis was used (http://string-db.org).
Quantitative PCR (qPCR) RNA was extracted from either tissue, cells, or neotissues using the RNeasy kit (Qiagen). For validation of array analysis, quantitative PCR was performed on several genes identified as DE between the tissue and cells in monolayer culture. RNA was extracted from avascular tissue or cultureexpanded cells from menisci of three additional human donors (see information above). RNA was also extracted from cells in 3D culture. Synthesis of cDNA was performed using total RNA as a template according to the manufacturer's protocols (Applied Biosystems, Foster City, CA). Pre-validated TaqMan 1 gene expression reagents (Applied Biosystems) were used for quantitative RT-PCR. The expression levels of the identified DE genes were normalized to GAPDH using the DCt method as previously reported. 29 Significant changes in gene expression in 3D cultures in comparison to monolayer cultures were calculated using the online BootstRatio application, where p values of less than 0.05 were considered significant (http://regstattools.net/br). 40 Three-Dimensional (3D) Culture Systems for Neotissue Formation Human avascular meniscus cells were mixed with a hydrogel composed of Collagen type II (3 mg/ml), Chondroitin sulfate (2.8 mg/ml), and Hyaluronan (3 mg/ml) and were used for high-density pellet cultures. To form pellet cultures, 0.5 Â 10 6 cells mixed with 50 ml of ECM hydrogel were centrifuged at 800 rpm for 5 min in 0.5 ml serum-free medium. The serumfree medium was composed of DMEM (Mediatech), 1Â ITSþ medium (Sigma), 1.25 mg/ml human serum albumin (Bayer, Leverkusen, Germany), 100 nM dexamethasone (Sigma),
0.1 mM ascorbic acid2-phosphate (Sigma), and 1% penicillin/ streptomycin/gentamycin (Gibco). As detailed later, the serum-free medium was supplemented with various combinations of growth factors including TGFb1 and BMP6 (PeproTech, Rocky Hill, NJ) for 14 days.
Histology and Immunostaining
Neotissues were fixed in Z-fix (Anatech, San Diego, CA), embedded in paraffin, and were assessed by H&E and Safranin-O staining. Immunohistochemistry analysis was conducted to examine protein deposition of collagen type I (clone: I-8H5; MP Biomedicals, Santa Ana, CA) at a concentration of 10 mg/ml as previously described. 41 A goat antimouse biotinylated secondary antibody was used (Vector Laboratories, Burlingame, CA), followed by color development using the Vectastain ABC-AP standard kit (Vector). A species-matched isotype control was used in parallel to monitor nonspecific staining.
RESULTS

Unique Gene Expression Profiles for Avascular Meniscus Tissue and Cells in Monolayer Culture
Ranking analysis revealed a total of 387 DE genes between the tissue and the culture-expanded cells (log2-fold, p < 0.01). Using these criteria, the magnitude of fold change (MagFC) of these DE genes was greater than threefold. A total of 188 genes were increased in the native tissue versus 199 genes in 2 week monolayer cultured avascular meniscus cells. The top 20 DE genes from avascular meniscus tissue and in 2-week cultured meniscus cells are shown in Tables 1 and 2 , respectively. For a complete list of all DE genes, see Supplementary Material, Tables S1 and S2.
Phenotype States Are Dominated by Growth Factor, ECM, and Cytoskeleton Pathways DAVID analyses implicated several pathways that were differentially regulated (Tables 3 and 4) . For avascular meniscus tissue, KEGG pathways that were upregulated included ECM-receptor interaction, transforming growth factor beta (TGFb), and plateletderived growth factor (PDGF) signaling, and focal adhesion (Table 3) . Several genes were common to most of these pathways including Laminin subunit gamma-3 (LAMC3), COMP, integrin alpha 10 (ITGA10), chondroadherin (CHAD), thrombospondin 4 (THBS4), and bone morphogenetic protein 6 (BMP6). The platelet-derived growth factor (PDGF) signaling pathway, a Reactome Pathway category, mainly involved protein kinases and other molecules involved in actin cytoskeleton regulation.
Major pathways involved in dedifferentiation during monolayer culture included lysosome, focal adhesion, ECM-receptor interaction, and regulation of actin cytoskeleton, hemostasis, and signaling by PDGF ( in the ranking analysis, for each particular condition (see gene list in Supplementary Material, Tables S1  and S2 ). The STRING analysis of the tissue data revealed similar observations as generated in the DAVID analysis including the molecules involved in ECM-receptor interaction and focal adhesion. However, STRING also indicated the potential involvement of growth factors (BMP6 and FGF2) and specific transcription factors, including hairy and enhancer of split 1 (HES1), inhibitor of DNA binding 2 (ID2) and AVASCULAR MENISCUS GENE EXPRESSION PROFILING SRY (sex determining region Y)-box 9 (SOX9) that may mediate the meniscus tissue phenotype (Fig. 1A) . STRING analysis indicated interaction of molecules that mediate focal adhesion and cytoskeleton regulation during dedifferentiation (after monolayer cell culture) (Fig. 1B) . The interactions implicated additional molecules likely to be involved in mediating such focal adhesion and cytoskeleton profiles in dedifferentiated meniscus cells. These include four and a half LIM domains 2 (FHL2), tubulin alpha 1a (TUBA1A), Profilin 1 (PFN1), and Gap Junction Protein alpha 1 (GJA1) also known as Connexin 43 (CX43). The cytokine CXCL12 (also called stromal cellderived factor 1, SDF-1) and matrix metalloproteinase 9 (MMP9) also interact with THBS2, collagen (collagen type I) and integrins. 42 To validate the results of the array screen, DAVID and STRING pathway analyses, RNA from three additional donors (matched tissue and cultured cells from each donor) was extracted. A total of 10 genes were chosen for validation by qPCR. Seven of these genes are listed in the top 20 (Tables 1 and 2 ) and three were selected from the pathway analysis (Tables 3 and 4 ). Six genes with significantly higher expression in the native tissues were tested: THBS4, SOX9, clusterin (CLU), COMP, cartilage intermediate layer protein (CILP), and CHAD. All six genes were expressed greater than 80-fold higher (p < 0.03) in the tissue samples compared to the monolayer cultured avascular meniscus cells (Supplementary Material,  Fig. S1A ). Four genes with significantly higher expression in cells in monolayer culture were tested by qPCR for validation: Thymus cell antigen 1 (THY1), Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1), thrombospondin 2 (THBS2), and collagen type I, alpha1 (COL1A1). These genes were at least twofold greater (p < 0.05) in monolayer-cultured cells relative to the native tissue (Supplementary Material, Fig. S1B ).
Three-Dimensional Culture Conditions Lead to Partial Reversion of Meniscus Tissue Gene-Expression Profiles
In addition, to providing insights into the dedifferentiating phenotype, these results and analysis are valuable for constructing a target phenotype enabling the development of culture conditions for meniscal differentiation and facilitating engineering meniscal tissue. We cultured human meniscus cells from four additional donors in the presence of TGFb1 (10 ng/ml) in high-density pellets for 2 weeks and assessed for meniscus neotissue formation via histology, immunohistochemistry, and gene expression (Fig. 2) . The neotissues resembled meniscus tissues with a composition of mixed chondrocytic-fibroblastic cell morphologies ( Fig. 2A-E) , with low background GAG staining (Fig. 2C-D) and high collagen type I protein deposition (Fig. 2E) . As evidence of redifferentiation, several genes originally identified as being highly expressed in avascular meniscus tissues were upregulated in 3D-cultured neotissues relative to monolayer culture, including CHAD (p < 0.07), CLU (p < 0.01), CILP (nsd), SOX8 (nsd), and SOX9 (p < 0.04) (Fig. 2G) . Conversely, a corresponding decrease in THBS2 (p < 0.01) and THY1 (p < 0.01) expression in 3D cultured neotissues supported loss of dedifferentiated status (Fig. 2I) . Consistent with histologic findings, COL1A1 increased while aggrecan (ACAN) mRNA levels were low.
While TGFb1 induced formation of neotissue with the gene expression profile resembling that of avascular meniscus tissue, we did not find the expected increase in ACAN and THBS4 expression (significantly lower, p < 0.01). Because STRING analysis had indicated a possible role for BMP6 in maintaining or promoting the meniscus phenotype, we cultured human avascular meniscus cells from four more donors in 3D high-density pellets with BMP6 (10 or 100 ng/ml) alone or in combination with TGFb1 (TGFb1 10ng/mlþ BMP6 10 ng/ml; 10 ng/ml þ BMP6 100 ng/ml). Combining BMP6 and TGFb1 increased ACAN (p < 0.07) and THBS4 (p < 0.001) expression levels relative to monolayer cultured cells (Fig. 2J) . In agreement with a meniscus tissue phenotype, this combination of growth factors increased SOX9 mRNA levels (p < 0.04) and decreased THBS2 (p < 0.02) and THY1 (p < 0.01) expression.
To determine the role of newly identified molecules in mediating differentiation states, we also monitored the expression of ID2, HES1, and FLH2 in 3D pellet cultures treated with TGFb1 þ BMP6. Consistent with the avascular meniscus phenotype, FLH-2 mRNA levels decreased (p < 0.05) and HES1 expression levels increased (p < 0.03); although no significant change in ID2 expression was detected (Supplementary Material, Fig. S2 ).
DISCUSSION
Regenerating the avascular region of the meniscus using a cell-based approach is challenging on many levels. The overlapping characteristics of meniscal cells with chondrocytes and fibroblasts make it difficult to define a clear phenotype with identifiable markers. Cell expansion commonly induces dedifferentiation, which has been well documented for chondrocytes but less clearly defined for meniscal cells. In addition, conditions for redifferentiation of meniscal cells are largely unknown. The goal of this study was to document gene-expression profiles and to identify important molecules associated with the significant changes involved in the dedifferentiation induced during cell expansion. Our data reveal a number of molecules and pathways that provide directions to better understand the meniscus phenotype. We utilized these baseline-expression profiles as targets to develop culture conditions to induce the formation of avascular meniscus-like neotissue from culture-expanded avascular meniscus cells.
We ranked the DE genes to identify those with the greatest fold change and performed pathways analyses (DAVID and STRING) on the meniscus tissue and on the culture-expanded cells. Interestingly, for both differentiation states, the same pathways were identified; namely ECM-receptor interaction, focal adhesion and TGFb, and PDGF signaling. Nevertheless, the genes identified in these pathways were unique for each differentiation state.
Common to most of the pathways identified in normal avascular meniscus tissue were the expression (B10 ¼ BMP6 at 10 ng/ml; B100 ¼ BMP6 at 100 ng/ml; BT10 ¼ Both TGFb1, and BMP6 at 10 ng/ml; T10B100 ¼ TGFb1 at 10 ng/ml and BMP6 at 100 ng/ml). ( Ã p < 0.05; #p < 0.07).
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of similar genes including LAMC3, COMP, ITGA10, CHAD, THBS4, and BMP6. Central to the ECM molecules identified, as revealed by STRING analysis, is integrin alpha 10 (ITGA10), only known to bind collagen type II, 43 which is known to be present in avascular meniscus tissue. 44 COL2A1 is known to be expressed in the avascular meniscus region. However, in our study, the change in relative expression of COL2A1 between the conditions was not high enough to be ranked among the DE genes. Future work will be required to validate this integrin's role for maintaining the avascular meniscus phenotype. Other important components of this ECM mix of molecules are the thrombospondins (THBS). THBS-5 is also known as Cartilage Oligomeric Matrix Protein (COMP). 45 Both THBS4 and COMP were upregulated in meniscus tissue, and both interact with many ECM molecules. [46] [47] [48] [49] COMP is important in fibril formation and ECM assembly 50 and promotes attachment of ligament cells and chondrocytes to components of ECM.
51 THBS4 mediates cell-to-cell and cell-to-matrix interactions within the ECM. [52] [53] [54] COMP and LAMC3 also orchestrate TGFb signaling, 55 ,56 which we show to be important for stimulation of neo-meniscus tissue.
Chondroadherin (CHAD) was expressed with the highest fold change in meniscus tissue, validated by qPCR, and implicated in ECM-receptor interaction and focal adhesion pathways. CHAD is a small leucine-rich repeat protein (SLRP) associated with collagen fibril formation. 57, 58 CHAD binds to many ECM molecules including the a2b1 integrin 44, 59 and cell surface proteoglycans, like syndecans 60 collagen types II and VI, 44, 61 not only to orchestrate signaling between chondrocytes and ECM but also to regulate linkages between collagens and other ECM molecules in vivo. Cartilage intermediate layer protein (CILP) was the next highly upregulated and validated gene in meniscus tissue. CILPs a large secreted glycoprotein 62 and is found to be present in the middle or intermediate zone of articular cartilage. 63 CILP plays a role in mediating growth factor signaling dynamics. Johnson et al. 64 showed that CILP expression reduces IGF-1 induced proteoglycan production. Overall, the pathway analysis indicates that combined known functions of LAMC3, COMP, CHAD, and THBS4 are likely critical for the maintenance of avascular meniscus ECM composition, organization and growth factor signaling.
Our data revealed that transcriptional control of the avascular meniscus tissue may be orchestrated through SOX8, SOX9, inhibitor of DNA binding 2 (ID2), and hairy and enhancer of split-1 (HES1). SOX9 is well known to co-ordinate transcription many ECM molecules like COL2A1, 65, 66 aggrecan, 67 and COMP. 68 However, the involvement of ID2 and HES1 may be unique to maintaining the avascular meniscus tissue phenotype (Fig. 1A) . We noted an increase in HES1 mRNA during redifferentiation with BMP6 and TGFb treatments (Supplementary Material, Fig. S2 ). Future studies on these transcription factors are necessary for understanding phenotype control in normal, regenerated, and diseased meniscus. Culturing avascular meniscus cells in standard cell culture flasks for 2 weeks led to a typical fibroblast-like cell morphology and a dramatic change in gene expression profiles that indicates dedifferentiation. This dedifferentiation response is common to cells cultured in monolayer culture from several tissues including smooth muscle cells, 69 adipocytes, 70 and articular chondrocytes. [71] [72] [73] The primary changes identified for dedifferentiated avascular meniscus cells involved many ECM and cytoskeletal components. The pathways identified by DAVID analysis included focal adhesion, ECM-receptor interaction, hemostasis, signaling by PDGF, and the regulation of actin cytoskeleton.
These pathways are clearly interconnected with many co-identified genes shared between the ECM, cell surface, and the cytoskeleton (see Table 4 and Fig. 1B ). The ECM-related genes identified as an adaption to monolayer culture include THBS2 and many collagens like COL1A1, COL6A1, COL8A1, and COL12A1. The cell interface of surface molecules appears to be mainly orchestrated by integrin, CD44 and CD90 (THY-1) and CD140a (platelet-derived growth factor receptor alpha, PDGFRA), which interact directly or indirectly with numerous cytoskeleton proteins. Changes in cytoskeleton are important in regulating cell phenotype, which are exemplified in studies of articular chondrocyte dedifferentiation. [71] [72] [73] [74] [75] Increased CD44, CD140a, and THY-1 (CD90) surface expression was also observed on dedifferentiated human chondrocytes 76 and in both vascular and avascular human meniscus cells.
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THBS2 was significantly upregulated while THBS4 was downregulated in culture-expanded cells. Under various 3D redifferentiation conditions, we were able to restore the relative expression profiles. This reversal in THBS4 and THBS2 expression may therefore be useful for monitoring the phenotype shift or for determining meniscus cell differentiation status; analogous to the shift between collagen type II and type I or aggrecan and versican in articular chondrocytes upon culture-induced dedifferentiation. 28, 29, 75 There are a few reports of the results of microarray analysis of human meniscus tissue or cells. Our study focused on normal avascular meniscus tissue and on the consequence of dedifferentiation. While this is unique in comparison to the other studies, there are some aspects related to the response to injury or because of OA that are noteworthy. Rai et al. 23 performed microarray and QuantiGene Plex analyses on tissue from partial meniscectomies to identify DE genes in torn menisci in relation to age and chondrosis. Certain traits of aging and disease seem to be related to cell dedifferentiation. Rai et al. 23 concluded that meniscal cells tended to dedifferentiate in older adults and initiate a proliferative phenotype, reflecting what we noted in culture-expanded meniscus cells. However, the pathways identified by Rai et al. 23 because of joint disease status were related more to cell cycle and inflammation, rather than to cell adhesion, growth factor signaling, and cytoskeleton changes as observed in our study.
In a comparison between normal and OA meniscal cells, Sun et al. 24 observed that OA meniscus cells upregulated genes associated with inflammation and cytokine production and also down-regulated genes related to DNA repair processes. The authors reported that disease was associated with increased expression of a disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5), insulin-like growth factor one binding protein 7 (IGFBP7), Cathepsin S (CTSS), secreted frizzled-related protein 4 (SFRP4), which again is consistent with evidence that the process of OA involves cell dedifferentiation. Our dataset also included similar changes in genes expression during monolayer cell culture, albeit different isoforms, such as ADAMTS1, IGFBP3, IGFBP4, CTSA, CTSZ, and SFRP4 (see Supplementary Material, Table S2 ).
Our second objective was to use these results to explore culture conditions conducive to redifferentiation in culture-expanded meniscal cells. We selected a subset of genes based on the ranking (fold change DE) and their relevance to pathways involving transcriptional regulation, ECM synthesis, and cell attachment: an increase in COL1A1, COMP, CHAD, CLU, CILP, SOX9, THBS4 and, conversely a decrease in THY-1, THBS2.
In agreement with other studies 78, 79 and the pathway analyses, we also observed that TGFb was a major driver for redifferentiation of culture-expanded meniscus cells. TGFb1 exposure in 3D cultures induced gene expression that was the closest to the native meniscal phenotype (with the exception of THBS4). In our study, a combination of TGFb1 and BMP6 induced an avascular meniscus phenotype with greater ACAN and THBS4 gene expression levels, while also inducing SOX9 and decreasing THBS2 and THY1. This is consistent with other work, where incorporating TGFb into biomaterials enhanced meniscus tissue formation 80, 81 and TGFb improved meniscus regeneration in animal models of meniscal injury. 5, 79, 82, 83 A combination of TGFb3 and BMP4 has also been shown to enhance fibrochondrogenesis of human embryonic stem cell embryoid bodies 84 displaying an expression of collagens type I, II, and VI.
There are several factors to consider with the current data set presented. We only focused on avascular tissue because of the clinical relevance to meniscal tears and lack of healing. Gene expression and cellular response in the vascular region are likely to be different. In addition, we pooled both medial and lateral avascular tissue regions, which eliminated the potential for discovery of unique expression profiles between these anatomical locations. We only utilized two donors for the microarray screen; however, ten additional donors were used in subsequent validation experiments to confirm key results of the microarray analysis. The array data set and the validation data set only included male donors and may not reflect differences between the sexes. However, the two female donors used in the subsequent 3D culture studies responded to conditions in a similar manner to the male cells. However, more donors would be needed to examine sexual differences. It is important to emphasize that the DE genes identified in this study were based only on differences generated during monolayer culture expansion of meniscus cells. These differences are highly relevant to tissue engineering, but cannot identify genes that are specific to the meniscus, which will necessitate comparisons with other tissues. We selected neotissue generated after 2 weeks in 3D pellet culture as a useful model to study redifferentiation. However, this is a dynamic model and differences are expected between mature and nascent tissue. Additional testing is required, including, for example, temporal growth factor exposure, longer culture periods, and mechanical loading to further mature and remodel newly formed tissues even closer to a mature avascular meniscus phenotype.
In conclusion, we monitored changes in gene expression in meniscal tissue, after monolayer and 3D culture, and in response to TGFb and BMP6. These changes provided insights into molecules and pathways that are important for the maintenance of avascular meniscus tissue. These results represent a useful step toward developing conditions for regenerating meniscus tissue from meniscus cells and other cell sources, such as mesenchymal stem cells. This study expands our understanding of meniscus biology and provides directions for future investigations leading to meniscus tissue regeneration.
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